Drugs Made In America Acquisition II Corp. (DMII)
Market Open
12 Jun, 14:49
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 08
0
0%
$
529.35M Market Cap
- P/E Ratio
- Div Yield
3 Volume
- Eps
$ 10.08
Previous Close 
Want to track DMII and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. (DMII) Statistics
Valuation metrics
Market Cap 529.35M
Enterprise value 5.67M
Trailing P/E (ttm) 0.59
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.17K
Average volume (90 days) 98.71K
Price summary
52-Week low 9.86
52-Week high 10.09
Beta -
50-Day moving average 10.03
200-Day moving average 9.97
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 0.53%
Book value per share (mrq) 7.72
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
